Skip to main content
Equibles

ZYDUSLIFE · Zydus Lifesciences Limited · Financials

Use ZYDUSLIFE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ZYDUSLIFE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,191.00 INR -14.50 (-1.20%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 29.01K Avg daily vol (3M) 103.01K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
271.48B +16.8%
FY2026 Revenue FY2018–FY2026
Net Income
50.4B +3326.2%
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
21.17B -68.8%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
INR 303.78B 271.48B 232.42B 195.47B 172.37B 152.65B 151.02B 142.53B 131.66B 119.36B
INR 20.27B 14.08B 9.16B 7.64B 7.23B 7.13B 7.25B 6.97B 5.99B 5.39B
INR 5.96B 4.39B 1.66B 812M 1.3B 1.27B 1.64B 3.42B 1.94B 911M
INR 13.95B 15.95B 14.12B 9.78B 5.88B 5.12B 1.47B 3.2B 5.3B 5.64B
INR 41.8B 50.4B 1.47B 1.13B 19.6B 44.87B 21.34B 11.77B 18.49B 17.76B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 26.69B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.